The dumb money always gets suckered into the market at the wrong time.
You don’t have to dig up your old history books to find the proof, either. Just look back a few months to December. Your average investor took his money and ran as far from stocks as possible because he was worried the fiscal cliff would tear the markets apart.
Now, after record inflows into the stock market earlier this year, it looks like individual investors are taking some money off the table. According to a research report from Bank of America Merrill Lynch, the firm’s private clients are signaling retreat…
“BofAML private clients–who have been the sole net buyers of US stocks this year– have begun to take profits as the S&P 500 continued its ascent,” the report reads. “This group has now sold stocks in three of the last six weeks, after near-record net buying earlier this year.”
That didn’t take long…
But as individual investors begin to back out of the market, the smart money has been more than happy to pick up their shares–and then some.
Hedge funds started buying at record rates last week, picking up large positions in the consumer discretionary and financial sector, as well as ETFs.
According to the BofA Merrill Lynch report, last week’s net buys of consumer discretionary and net sales of utilities were the largest on record. That’s some pretty bullish action. Utilities are considered a defensive sector, while consumer discretionary stocks are largely dependent on big spending from the general public…
Of course, there are no guarantees that the smart money is making the right move here. But it would be wise for you to keep some skin in the game if big players are going to continue piling into stocks.
for The Daily Reckoning
Greg Guenthner, CMT, is the managing editor of The Rude Awakening. Greg is a member of the Market Technicians Association and holds the Chartered Market Technician designation.
Charles Hugh Smith reports on why papering over the structural imbalances in the Eurozone with bailouts or bail-ins will not resolve the fundamental asymmetries in trade...
Chuck Butler discusses the stimulus in China and what he sees are the differences, plus details as Greece arrives in Brussels with their latest proposal for an agreement. All that and more in today's Daily Pfennig...
Jim Rickards updates his "There Will Be No 'Grexit'" thesis as two stories dominate global financial headlines. Find out why global capital markets are a tale of two crises.
No, Greece won't wreck the financial world. And neither will China. But we're still on alert... Dave Gonigam reports...
The most promising and exciting advance in all the history of medicine is upon us, and yet it is actually not new at all — it’s as old as humans. The advance? Our immune systems. Stephen Petranek has more on how immunotherapy could change the way we treat cancer
With the oil sector cruising in low gear since last year’s price collapse, should you be investing in oil companies? Yes, according to our friends at Sprott, Henry and Rick — especially if you look at mid-stream companies, which move oil from point A to point B. Since oil moves no matter the price, they make money no matter the price!
Just a few days ago, I noticed that 70 biotech stocks were in the green on the week -- a week where almost every single S&P component was in the red on Monday afternoon. So we hitched our wagon to health care stocks. And these stocks have remained strong in the face of a hurricane of negative news hitting the airwaves.